Sudeep Pharma Ltd has announced its IPO price band at ₹563–₹593 per share, with the issue opening on November 21 and closing on November 25. The ₹895 crore offering includes a fresh issue of ₹95 crore and an offer-for-sale of ₹800 crore by existing shareholders.
Sudeep Pharma gears up for market debut
Sudeep Pharma Ltd, a leading manufacturer of excipients and specialty ingredients for pharmaceutical, food, and nutrition industries, is set to launch its initial public offering later this month. The IPO will open for subscription on November 21, 2025, and close on November 25, 2025. The company has fixed the price band at ₹563–₹593 per share, with a minimum lot size of 25 shares, requiring an investment of ₹14,075 at the lower band and ₹14,825 at the upper band.
The issue comprises a fresh issue of ₹95 crore and an offer-for-sale of ₹800 crore by promoters and existing shareholders. The allotment is expected on November 26, with listing likely on November 28 on both BSE and NSE. ICICI Securities is the lead manager, while MUFG Intime India Pvt. Ltd. is the registrar.
Notable updates
-
IPO size: ₹895 crore (₹95 crore fresh issue + ₹800 crore OFS)
-
Price band: ₹563–₹593 per share
-
Subscription window: November 21–25, 2025
-
Minimum lot size: 25 shares (₹14,075–₹14,825 investment)
-
Tentative allotment on November 26; listing on November 28
-
ICICI Securities as lead manager; MUFG Intime India as registrar
Sources: NDTV Profit, Chanakya Nipothi, Moneycontrol